Research output per year
Research output per year
Research output
- 50 - 80 out of 80 results
Search results
-
2014
A 3-weekly schedule of irinotecan and panitumumab for wild-type KRAS metastatic colorectal cancer
Hansen, T. F., Fredslund Andersen, R., Pallisgaard, N., Spindler, K.-L. G., Pløen, J., Keldsen, N., Lindebjerg, J., Sørensen, F. B. & Jakobsen, A., 2014, In: Colorectal Cancer. 3, 2, p. 135-145Research output: Contribution to journal › Journal article › Research › peer-review
-
Cell-free DNA in healthy individuals, noncancerous disease and strong prognostic value in colorectal cancer
Spindler, K.-L. G., Appelt, A. L., Pallisgaard, N., Andersen, R. F., Brandslund, I. & Jakobsen, A., 2014, In: International Journal of Cancer. 135, 12, p. 2984–2991Research output: Contribution to journal › Journal article › Research › peer-review
-
Changes in mutational status during third-line treatment for metastatic colorectal cancer: results of consecutive measurement of cell free DNA, KRAS and BRAF in the plasma
Spindler, K.-L. G., Pallisgaard, N., Andersen, R. F. & Jakobsen, A., 1. Nov 2014, In: International Journal of Cancer. 135, 9, p. 2215-2222Research output: Contribution to journal › Journal article › Research › peer-review
-
Gemcitabine and capecitabine for heavily pre-treated metastatic colorectal cancer patients: a phase II and translational research study
Spindler, K.-L. G., Pallisgaard, N., Andersen, R. F., Ploen, J. & Jakobsen, A., Feb 2014, In: Anticancer Research. 34, 2, p. 845-850Research output: Contribution to journal › Journal article › Research › peer-review
-
Levels of cell-free DNA and plasma KRAS during treatment of advanced NSCLC
Dowler Nygaard, A., Spindler, K.-L. G., Pallisgaard, N., Andersen, R. F. & Jakobsen, A., Feb 2014, In: Current Oncology Reports. 31, 2, p. 969-974 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Prognostic importance of cell-free DNA in chemotherapy resistant ovarian cancer treated with bevacizumab
Steffensen, K. D., Madsen, C. V., Andersen, R. F., Waldstrøm, M., Adimi, P. & Jakobsen, A., Oct 2014, In: European Journal of Cancer. 50, 15, p. 2611-2618 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
2013
KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer
Spindler, K. G., Appelt, A. L., Pallisgaard, N., Andersen, R. F. & Jakobsen, A., 10. Dec 2013, In: British Journal of Cancer. 109, 12, p. 3067-3072 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
MicroRNA-126 and epidermal growth factor-like domain 7-an angiogenic couple of importance in metastatic colorectal cancer. Results from the Nordic ACT trial
Hansen, T. F., Christensen, R. D., Andersen, R. F., Sørensen, F. B., Johnsson, A. & Jakobsen, A., 3. Sept 2013, In: British Journal of Cancer. 109, 5, p. 1243-1251 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Pemetrexed and Gemcitabine for Chemotherapy Refractory Colorectal Cancer-Results of a Phase II and Translational Research Study
Spindler, K.-L. G., Pallisgaard, N., Fredslund Andersen, R., Pløen, J. & Jakobsen, A., 2013, In: Journal of Cancer Therapy. 4, p. 44-50Research output: Contribution to journal › Journal article › Research › peer-review
-
Phase II trial of temsirolimus alone and in combination with irinotecan for KRAS mutant metastatic colorectal cancer: Outcome and results of KRAS mutational analysis in plasma
Spindler, K.-L. G., Sorensen, M. M., Pallisgaard, N., Andersen, R. F., Havelund, B. M., Ploen, J., Lassen, U. & Jakobsen, A. K. M., Jun 2013, In: Acta Oncologica. 52, 5, p. 963-970 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Plasma HER2 amplification in cell-free DNA during neoadjuvant chemotherapy in breast cancer
Bechmann, T., Andersen, R. F., Pallisgaard, N., Madsen, J. S., Maae, E., Jakobsen, E. H., Bak Jylling, A. M., Steffensen, K. D. & Jakobsen, A., Jun 2013, In: Journal of Cancer Research and Clinical Oncology. 139, 6, p. 995-1003 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Serum HER-2: Sensitivity, specificity, and predictive values for detecting metastatic recurrence in breast cancer patients
Sørensen, P. D., Jakobsen, E. H., Madsen, J. S., Petersen, E. B., Andersen, R. F., Østergaard, B. & Brandslund, I., Jun 2013, In: Journal of Cancer Research and Clinical Oncology. 139, 6, p. 1005-1013 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
The Influence of Tissue Ischemia on Biomarker Expression in Colorectal Cancer
Havelund, B. M., Aalund Olsen, D., Andersen, R. F., Spindler, K.-L. G., Brandslund, I., Jakobsen, A. & Soerensen, F. B., 2013, In: Applied Immunohistochemistry & Molecular Morphology. 21, 4, p. 298-307Research output: Contribution to journal › Journal article › Research › peer-review
-
The prognostic value of KRAS mutated plasma DNA in advanced non-small cell lung cancer
Nygaard, A. D., Garm Spindler, K.-L., Pallisgaard, N., Andersen, R. F. & Jakobsen, A., Mar 2013, In: Lung Cancer. 79, 3, p. 312-317Research output: Contribution to journal › Journal article › Research › peer-review
-
2012
Platelet-Derived Growth Factor Gene Polymorphisms in Patients With Ovarian Cancer
Madsen, C. V., Dahl Steffensen, K., Waldstrøm, M., Fredslund Andersen, R., Søgaard, C., Brandslund, I. & Jakobsen, A., 2012, In: Clinical Ovarian and Other Gynecologic Cancer. 5, 1, p. 10-16Research output: Contribution to journal › Journal article › Research › peer-review
-
Prognostic Impact of VEGFA Germline Polymorphisms in Patients with HER2-positive Primary Breast Cancer
Maae, E., Fredslund Andersen, R., Dahl Steffensen, K., Jakobsen, E. H., Brandslund, I., Sørensen, F. B. & Jakobsen, A., 2012, In: Anticancer Research. 32, 9, p. 3619-3627Research output: Contribution to journal › Journal article › Research › peer-review
-
Single nucleotide polymorphisms in the HIF-1α gene and chemoradiotherapy of locally advanced rectal cancer
Havelund, B. M., Spindler, K.-L. G., Ploen, J., Andersen, R. F. & Jakobsen, A., 2012, In: Oncology Letters. 4, 5, p. 1056-1060 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
The predictive value of single nucleotide polymorphisms in the VEGF system to the efficacy of first-line treatment with bevacizumab plus chemotherapy in patients with metastatic colorectal cancer : Results from the Nordic ACT trial
Hansen, T. F., Christensen, R. D., Andersen, R. F., Spindler, K.-L. G., Johnsson, A. & Jakobsen, A., 2012, In: International Journal of Colorectal Disease. 27, 6, p. 715-720Research output: Contribution to journal › Journal article › Research › peer-review
-
2011
The predictive value of genetic variations in the vascular endothelial growth factor A gene in metastatic colorectal cancer
Hansen, T. F., Spindler, K.-L. G., Fredslund Andersen, R., Lindebjerg, J., Brandslund, I. & Jakobsen, A., 2011, In: Pharmacogenomics Journal. 11, 1, p. 53-60Research output: Contribution to journal › Journal article › Research › peer-review
-
VEGF in the development of ovarian malignancy
Smerdel, M., Dahl Steffensen, K., Waldstrøm, M., Fredslund Andersen, R., Olsen, D. A., Brandslund, I. & Jakobsen, A., 2011, In: Clinical Ovarian Cancer. 4, 1, p. 19-25Research output: Contribution to journal › Journal article › Research › peer-review
-
2010
Microvessel density and the association with single nucleotide polymorphisms of the vascular endothelial growth factor receptor 2 in patients with colorectal cancer
Hansen, T. F., Sørensen, F. B., Spindler, K.-L. G., Olsen, D. A., Andersen, R. F., Lindebjerg, J., Brandslund, I. & Jakobsen, A., 1. Mar 2010, In: Virchows Archiv. 456, 3, p. 251-60 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
The Predictive Value of Germline Polymorphisms in Patients with NSCLC
Nygaard, A. D., Spindler, K.-L. G., Fredslund Andersen, R. & Jakobsen, A., 2010, In: Journal of Cancer Therapy. 1, p. 219-228Research output: Contribution to journal › Journal article › Research › peer-review
-
The Prognostic Value of Haplotypes in the Vascular Endothelial Growth Factor: A Gene in Colorectal Cancer
Hansen, T. F., Spindler, K.-L. G., Fredslund Andersen, R., Lindebjerg, J., Kølvraa, S., Brandslund, I. & Jakobsen, A., 2010, In: Cancers. 2, 3, p. 1405-1418Research output: Contribution to journal › Journal article › Research › peer-review
-
2009
Functional and prognostic influence of receptor polymorphisms in the vascular endothelial growth factor system in colorectal cancer
Hansen, T., Spindler, K. G., Aalund Olsen, D., Andersen, R. F., Lindebjerg, J., Brandslund, I. & Jakobsen, A., 20. May 2009, In: Journal of Clinical Oncology. 27, Suppl. 15, p. e15032Research output: Contribution to journal › Journal article › Research › peer-review
-
Prognostic importance of vascular endothelial growth factor-A expression and vascular endothelial growth factor polymorphisms in epithelial ovarian cancer
Smerdel, M., Waldstrøm, M., Brandslund, I., Steffensen, K. D., Andersen, R. F. & Jakobsen, A., 1. May 2009, In: International Journal of Gynecological Cancer. 19, 4, p. 578-84 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Quantitative analysis of the vascular endothelial growth factor receptor 1 and 2 in colorectal cancer
Hansen, T., Spindler, K.-L. G., Lorentzen, K. A., Olsen, D. A., Fredslund Andersen, R., Lindebjerg, J., Brandslund, I. & Jakobsen, A., 2009, In: Molecular Medicine Reports. 2, 5, p. 787-792Research output: Contribution to journal › Journal article › Research › peer-review
-
The importance of -460 C/T and +405 G/C single nucleotide polymorphisms to the function of vascular endothelial growth factor A in colorectal cancer
Hansen, T. F., Spindler, K.-L. G., Lorentzen, K. A., Olsen, D. A., Andersen, R. F., Lindebjerg, J., Brandslund, I. & Jakobsen, A., 11. Nov 2009, In: Journal of Cancer Research and Clinical Oncology. 136, 5, p. 751-758Research output: Contribution to journal › Journal article › Research › peer-review
-
The importance of KRAS mutations and EGF61A>G polymorphism to the effect of cetuximab and irinotecan in metastatic colorectal cancer
Spindler, K.-L. G., Pallisgaard, N., Rasmussen, A. A., Lindebjerg, J., Andersen, R. F., Crüger, D. & Jakobsen, A., 29. Jan 2009, In: Annals of Oncology. 20, 5, p. 879-884Research output: Contribution to journal › Journal article › Research › peer-review
-
2008
Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER3 and HER4 in benign and malignant ovarian tumors
Dahl Steffensen, K., Waldstrøm, M., Fredslund Andersen, R., Olsen, D. A., Jeppesen, U., Knudsen, H. J., Brandslund, I. & Jakobsen, A., 1. Jul 2008, In: International Journal of Oncology. 33, 1, p. 195-204 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA)
Cottingham, M. G., Andersen, R. F., Spencer, A. J., Saurya, S., Furze, J., Hill, A. V. S. & Gilbert, S. C., 1. Jan 2008, In: PLOS ONE. 3, 2, p. e1638Research output: Contribution to journal › Journal article › Research › peer-review